NasdaqGS - Nasdaq Real Time Price USD

Intuitive Surgical, Inc. (ISRG)

Compare
489.86 -4.15 (-0.84%)
At close: September 13 at 4:00 PM EDT
490.00 +0.14 (+0.03%)
After hours: September 13 at 7:50 PM EDT
Loading Chart for ISRG
DELL
  • Previous Close 494.01
  • Open 490.01
  • Bid 489.79 x 100
  • Ask 490.02 x 100
  • Day's Range 489.27 - 496.18
  • 52 Week Range 254.85 - 496.18
  • Volume 1,179,270
  • Avg. Volume 1,517,496
  • Market Cap (intraday) 174.074B
  • Beta (5Y Monthly) 1.39
  • PE Ratio (TTM) 84.02
  • EPS (TTM) 5.83
  • Earnings Date Oct 17, 2024 - Oct 21, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 490.63

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.

www.intuitive.com

13,676

Full Time Employees

December 31

Fiscal Year Ends

Recent News: ISRG

View More

Performance Overview: ISRG

Trailing total returns as of 9/13/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

ISRG
45.20%
S&P 500
17.95%

1-Year Return

ISRG
62.45%
S&P 500
26.09%

3-Year Return

ISRG
43.59%
S&P 500
26.18%

5-Year Return

ISRG
180.93%
S&P 500
86.94%

Compare To: ISRG

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: ISRG

View More

Valuation Measures

Annual
As of 9/13/2024
  • Market Cap

    174.07B

  • Enterprise Value

    169.32B

  • Trailing P/E

    84.17

  • Forward P/E

    64.94

  • PEG Ratio (5yr expected)

    4.21

  • Price/Sales (ttm)

    23.26

  • Price/Book (mrq)

    11.84

  • Enterprise Value/Revenue

    22.36

  • Enterprise Value/EBITDA

    70.38

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    27.65%

  • Return on Assets (ttm)

    7.99%

  • Return on Equity (ttm)

    15.77%

  • Revenue (ttm)

    7.57B

  • Net Income Avi to Common (ttm)

    2.09B

  • Diluted EPS (ttm)

    5.83

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    4.76B

  • Total Debt/Equity (mrq)

    1.91%

  • Levered Free Cash Flow (ttm)

    372.34M

Research Analysis: ISRG

View More

Company Insights: ISRG

Research Reports: ISRG

View More

People Also Watch